STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancreatic cancer: An open label, phase I/IIa trial

eClinicalMedicine(2023)

引用 3|浏览22
暂无评分
摘要
The present study was supported by the Japan Agency for Medical Research and Development (AMED).
更多
查看译文
关键词
Unresectable pancreatic cancer,Carbohydrate sulfotransferase 15 (CHST15),STNM01,Tumor-infiltrating CD3+ and CD8+ T cells,Endoscopic ultrasound-guided fine needle injection
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要